Medidata, a global provider of cloud-based solutions for clinical research in life sciences, and CRO  Pharmaceutical Product Development (PPD), announced they are expanding their partnership around risk-based monitoring.   This effort combines processes to increase data sampling and tracking of source  document verification (SDV) through Medidata TSDV (targeted source document  verification) with site health assessments and risk evaluation through PPD’s  adaptive and intelligent monitoring. This new endeavor will afford clinical research  associates increased scrutiny of targeted endpoints that pose the greatest areas of  risk in studies. Through this new arrangement, the companies will track specific  SDV requirements and compliance directly within EDC systems  and will have greater opportunity to focus remote monitoring on targeted criticaldata points.

News

Medidata and PPD announced they are expanding their partnership around risk-based monitoring.